Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade gliomas patients

Trial Profile

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade gliomas patients

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 15 Jul 2017

At a glance

  • Drugs Olaparib (Primary) ; Temozolomide
  • Indications Glioma
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms OLA-TMZ-RTE-01
  • Most Recent Events

    • 19 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top